0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Eye Syndrome Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-31K8891
Home | Market Reports | Health| Vision Care
Global Dry Eye Syndrome Market Outlook 2022
BUY CHAPTERS

Global Dry Eye Syndrome Market Research Report 2024

Code: QYRE-Auto-31K8891
Report
January 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dry Eye Syndrome Market Size

The global Dry Eye Syndrome market was valued at US$ 5385 million in 2023 and is anticipated to reach US$ 7355.1 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.

Dry Eye Syndrome Market

Dry Eye Syndrome Market

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
In this report, we mainly study the drugs and eye drops for dry eye.
Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.
North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.
In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Syndrome.

Report Scope

The Dry Eye Syndrome market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Eye Syndrome manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation

Scope of Dry Eye Syndrome Market Report

Report Metric Details
Report Name Dry Eye Syndrome Market
Accounted market size in 2023 US$ 5385 in million
Forecasted market size in 2030 US$ 7355.1 million
CAGR 4.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Others
Segment by Distribution Channel
  • Hospital
  • Retail Pharmacy
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dry Eye Syndrome manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dry Eye Syndrome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Dry Eye Syndrome Market growing?

Ans: The Dry Eye Syndrome Market witnessing a CAGR of 4.5% during the forecast period 2024-2030.

What is the Dry Eye Syndrome Market size in 2030?

Ans: The Dry Eye Syndrome Market size in 2030 will be US$ 7355.1 million.

What is the market share of major companies in Dry Eye Syndrome Market?

Ans: Global top five manufacturers hold a share over 60%.

What is the Dry Eye Syndrome Market share by type?

Ans: In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%.

Who are the main players in the Dry Eye Syndrome Market report?

Ans: The main players in the Dry Eye Syndrome Market are Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group

What are the Type segmentation covered in the Dry Eye Syndrome Market report?

Ans: The Types covered in the Dry Eye Syndrome Market report are Artificial Tears, Anti-inflammatory Drugs, Others

1 Dry Eye Syndrome Market Overview
1.1 Product Overview and Scope of Dry Eye Syndrome
1.2 Dry Eye Syndrome Segment by Type
1.2.1 Global Dry Eye Syndrome Market Value Comparison by Type (2024-2030)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Others
1.3 Dry Eye Syndrome Segment by Distribution Channel
1.3.1 Global Dry Eye Syndrome Market Value by Distribution Channel: (2024-2030)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Dry Eye Syndrome Market Size Estimates and Forecasts
1.4.1 Global Dry Eye Syndrome Revenue 2019-2030
1.4.2 Global Dry Eye Syndrome Sales 2019-2030
1.4.3 Global Dry Eye Syndrome Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dry Eye Syndrome Market Competition by Manufacturers
2.1 Global Dry Eye Syndrome Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dry Eye Syndrome Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dry Eye Syndrome Average Price by Manufacturers (2019-2024)
2.4 Global Dry Eye Syndrome Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dry Eye Syndrome, Product Type & Application
2.7 Dry Eye Syndrome Market Competitive Situation and Trends
2.7.1 Dry Eye Syndrome Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dry Eye Syndrome Players Market Share by Revenue
2.7.3 Global Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dry Eye Syndrome Retrospective Market Scenario by Region
3.1 Global Dry Eye Syndrome Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dry Eye Syndrome Global Dry Eye Syndrome Sales by Region: 2019-2030
3.2.1 Global Dry Eye Syndrome Sales by Region: 2019-2024
3.2.2 Global Dry Eye Syndrome Sales by Region: 2025-2030
3.3 Global Dry Eye Syndrome Global Dry Eye Syndrome Revenue by Region: 2019-2030
3.3.1 Global Dry Eye Syndrome Revenue by Region: 2019-2024
3.3.2 Global Dry Eye Syndrome Revenue by Region: 2025-2030
3.4 North America Dry Eye Syndrome Market Facts & Figures by Country
3.4.1 North America Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dry Eye Syndrome Sales by Country (2019-2030)
3.4.3 North America Dry Eye Syndrome Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dry Eye Syndrome Market Facts & Figures by Country
3.5.1 Europe Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dry Eye Syndrome Sales by Country (2019-2030)
3.5.3 Europe Dry Eye Syndrome Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Eye Syndrome Market Facts & Figures by Country
3.6.1 Asia Pacific Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dry Eye Syndrome Sales by Country (2019-2030)
3.6.3 Asia Pacific Dry Eye Syndrome Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dry Eye Syndrome Market Facts & Figures by Country
3.7.1 Latin America Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dry Eye Syndrome Sales by Country (2019-2030)
3.7.3 Latin America Dry Eye Syndrome Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Eye Syndrome Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Eye Syndrome Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dry Eye Syndrome Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dry Eye Syndrome Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dry Eye Syndrome Sales by Type (2019-2030)
4.1.1 Global Dry Eye Syndrome Sales by Type (2019-2024)
4.1.2 Global Dry Eye Syndrome Sales by Type (2025-2030)
4.1.3 Global Dry Eye Syndrome Sales Market Share by Type (2019-2030)
4.2 Global Dry Eye Syndrome Revenue by Type (2019-2030)
4.2.1 Global Dry Eye Syndrome Revenue by Type (2019-2024)
4.2.2 Global Dry Eye Syndrome Revenue by Type (2025-2030)
4.2.3 Global Dry Eye Syndrome Revenue Market Share by Type (2019-2030)
4.3 Global Dry Eye Syndrome Price by Type (2019-2030)
5 Segment by Distribution Channel
5.1 Global Dry Eye Syndrome Sales by Distribution Channel (2019-2030)
5.1.1 Global Dry Eye Syndrome Sales by Distribution Channel (2019-2024)
5.1.2 Global Dry Eye Syndrome Sales by Distribution Channel (2025-2030)
5.1.3 Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2019-2030)
5.2 Global Dry Eye Syndrome Revenue by Distribution Channel (2019-2030)
5.2.1 Global Dry Eye Syndrome Revenue by Distribution Channel (2019-2024)
5.2.2 Global Dry Eye Syndrome Revenue by Distribution Channel (2025-2030)
5.2.3 Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2019-2030)
5.3 Global Dry Eye Syndrome Price by Distribution Channel (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Dry Eye Syndrome Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Alcon
6.2.1 Alcon Corporation Information
6.2.2 Alcon Description and Business Overview
6.2.3 Alcon Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alcon Dry Eye Syndrome Product Portfolio
6.2.5 Alcon Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Dry Eye Syndrome Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Santen Pharma
6.4.1 Santen Pharma Corporation Information
6.4.2 Santen Pharma Description and Business Overview
6.4.3 Santen Pharma Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Santen Pharma Dry Eye Syndrome Product Portfolio
6.4.5 Santen Pharma Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Dry Eye Syndrome Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Bausch & Lomb
6.6.1 Bausch & Lomb Corporation Information
6.6.2 Bausch & Lomb Description and Business Overview
6.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bausch & Lomb Dry Eye Syndrome Product Portfolio
6.6.5 Bausch & Lomb Recent Developments/Updates
6.7 Thea pharmaceuticals
6.6.1 Thea pharmaceuticals Corporation Information
6.6.2 Thea pharmaceuticals Description and Business Overview
6.6.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thea pharmaceuticals Dry Eye Syndrome Product Portfolio
6.7.5 Thea pharmaceuticals Recent Developments/Updates
6.8 URSAPHARM
6.8.1 URSAPHARM Corporation Information
6.8.2 URSAPHARM Description and Business Overview
6.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.8.4 URSAPHARM Dry Eye Syndrome Product Portfolio
6.8.5 URSAPHARM Recent Developments/Updates
6.9 SIMILASAN
6.9.1 SIMILASAN Corporation Information
6.9.2 SIMILASAN Description and Business Overview
6.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SIMILASAN Dry Eye Syndrome Product Portfolio
6.9.5 SIMILASAN Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Akorn Dry Eye Syndrome Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 United Laboratories
6.11.1 United Laboratories Corporation Information
6.11.2 United Laboratories Dry Eye Syndrome Description and Business Overview
6.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.11.4 United Laboratories Dry Eye Syndrome Product Portfolio
6.11.5 United Laboratories Recent Developments/Updates
6.12 Sun Pharmaceutical
6.12.1 Sun Pharmaceutical Corporation Information
6.12.2 Sun Pharmaceutical Dry Eye Syndrome Description and Business Overview
6.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sun Pharmaceutical Dry Eye Syndrome Product Portfolio
6.12.5 Sun Pharmaceutical Recent Developments/Updates
6.13 Jianfeng Group
6.13.1 Jianfeng Group Corporation Information
6.13.2 Jianfeng Group Dry Eye Syndrome Description and Business Overview
6.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jianfeng Group Dry Eye Syndrome Product Portfolio
6.13.5 Jianfeng Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Eye Syndrome Industry Chain Analysis
7.2 Dry Eye Syndrome Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Eye Syndrome Production Mode & Process
7.4 Dry Eye Syndrome Sales and Marketing
7.4.1 Dry Eye Syndrome Sales Channels
7.4.2 Dry Eye Syndrome Distributors
7.5 Dry Eye Syndrome Customers
8 Dry Eye Syndrome Market Dynamics
8.1 Dry Eye Syndrome Industry Trends
8.2 Dry Eye Syndrome Market Drivers
8.3 Dry Eye Syndrome Market Challenges
8.4 Dry Eye Syndrome Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Dry Eye Syndrome Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Dry Eye Syndrome Market Value Comparison by Distribution Channel (2024-2030) & (US$ Million)
    Table 3. Global Dry Eye Syndrome Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Dry Eye Syndrome Sales (M Units) of Key Manufacturers (2019-2024)
    Table 5. Global Dry Eye Syndrome Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Dry Eye Syndrome Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Dry Eye Syndrome Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Dry Eye Syndrome Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Dry Eye Syndrome, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Dry Eye Syndrome, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Dry Eye Syndrome, Product Type & Application
    Table 12. Global Key Manufacturers of Dry Eye Syndrome, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Dry Eye Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dry Eye Syndrome Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Dry Eye Syndrome Sales by Region (2019-2024) & (M Units)
    Table 18. Global Dry Eye Syndrome Sales Market Share by Region (2019-2024)
    Table 19. Global Dry Eye Syndrome Sales by Region (2025-2030) & (M Units)
    Table 20. Global Dry Eye Syndrome Sales Market Share by Region (2025-2030)
    Table 21. Global Dry Eye Syndrome Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Dry Eye Syndrome Revenue Market Share by Region (2019-2024)
    Table 23. Global Dry Eye Syndrome Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Dry Eye Syndrome Revenue Market Share by Region (2025-2030)
    Table 25. North America Dry Eye Syndrome Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Dry Eye Syndrome Sales by Country (2019-2024) & (M Units)
    Table 27. North America Dry Eye Syndrome Sales by Country (2025-2030) & (M Units)
    Table 28. North America Dry Eye Syndrome Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Dry Eye Syndrome Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Dry Eye Syndrome Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Dry Eye Syndrome Sales by Country (2019-2024) & (M Units)
    Table 32. Europe Dry Eye Syndrome Sales by Country (2025-2030) & (M Units)
    Table 33. Europe Dry Eye Syndrome Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Dry Eye Syndrome Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Dry Eye Syndrome Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Dry Eye Syndrome Sales by Region (2019-2024) & (M Units)
    Table 37. Asia Pacific Dry Eye Syndrome Sales by Region (2025-2030) & (M Units)
    Table 38. Asia Pacific Dry Eye Syndrome Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Dry Eye Syndrome Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Dry Eye Syndrome Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Dry Eye Syndrome Sales by Country (2019-2024) & (M Units)
    Table 42. Latin America Dry Eye Syndrome Sales by Country (2025-2030) & (M Units)
    Table 43. Latin America Dry Eye Syndrome Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Dry Eye Syndrome Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Dry Eye Syndrome Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Dry Eye Syndrome Sales by Country (2019-2024) & (M Units)
    Table 47. Middle East & Africa Dry Eye Syndrome Sales by Country (2025-2030) & (M Units)
    Table 48. Middle East & Africa Dry Eye Syndrome Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Dry Eye Syndrome Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Dry Eye Syndrome Sales (M Units) by Type (2019-2024)
    Table 51. Global Dry Eye Syndrome Sales (M Units) by Type (2025-2030)
    Table 52. Global Dry Eye Syndrome Sales Market Share by Type (2019-2024)
    Table 53. Global Dry Eye Syndrome Sales Market Share by Type (2025-2030)
    Table 54. Global Dry Eye Syndrome Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Dry Eye Syndrome Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Dry Eye Syndrome Revenue Market Share by Type (2019-2024)
    Table 57. Global Dry Eye Syndrome Revenue Market Share by Type (2025-2030)
    Table 58. Global Dry Eye Syndrome Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Dry Eye Syndrome Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Dry Eye Syndrome Sales (M Units) by Distribution Channel (2019-2024)
    Table 61. Global Dry Eye Syndrome Sales (M Units) by Distribution Channel (2025-2030)
    Table 62. Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2019-2024)
    Table 63. Global Dry Eye Syndrome Sales Market Share by Distribution Channel (2025-2030)
    Table 64. Global Dry Eye Syndrome Revenue (US$ Million) by Distribution Channel (2019-2024)
    Table 65. Global Dry Eye Syndrome Revenue (US$ Million) by Distribution Channel (2025-2030)
    Table 66. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2019-2024)
    Table 67. Global Dry Eye Syndrome Revenue Market Share by Distribution Channel (2025-2030)
    Table 68. Global Dry Eye Syndrome Price (US$/Unit) by Distribution Channel (2019-2024)
    Table 69. Global Dry Eye Syndrome Price (US$/Unit) by Distribution Channel (2025-2030)
    Table 70. Allergan Corporation Information
    Table 71. Allergan Description and Business Overview
    Table 72. Allergan Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Allergan Dry Eye Syndrome Product
    Table 74. Allergan Recent Developments/Updates
    Table 75. Alcon Corporation Information
    Table 76. Alcon Description and Business Overview
    Table 77. Alcon Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Alcon Dry Eye Syndrome Product
    Table 79. Alcon Recent Developments/Updates
    Table 80. Novartis Corporation Information
    Table 81. Novartis Description and Business Overview
    Table 82. Novartis Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Novartis Dry Eye Syndrome Product
    Table 84. Novartis Recent Developments/Updates
    Table 85. Santen Pharma Corporation Information
    Table 86. Santen Pharma Description and Business Overview
    Table 87. Santen Pharma Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Santen Pharma Dry Eye Syndrome Product
    Table 89. Santen Pharma Recent Developments/Updates
    Table 90. Johnson & Johnson Corporation Information
    Table 91. Johnson & Johnson Description and Business Overview
    Table 92. Johnson & Johnson Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Johnson & Johnson Dry Eye Syndrome Product
    Table 94. Johnson & Johnson Recent Developments/Updates
    Table 95. Bausch & Lomb Corporation Information
    Table 96. Bausch & Lomb Description and Business Overview
    Table 97. Bausch & Lomb Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Bausch & Lomb Dry Eye Syndrome Product
    Table 99. Bausch & Lomb Recent Developments/Updates
    Table 100. Thea pharmaceuticals Corporation Information
    Table 101. Thea pharmaceuticals Description and Business Overview
    Table 102. Thea pharmaceuticals Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Thea pharmaceuticals Dry Eye Syndrome Product
    Table 104. Thea pharmaceuticals Recent Developments/Updates
    Table 105. URSAPHARM Corporation Information
    Table 106. URSAPHARM Description and Business Overview
    Table 107. URSAPHARM Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. URSAPHARM Dry Eye Syndrome Product
    Table 109. URSAPHARM Recent Developments/Updates
    Table 110. SIMILASAN Corporation Information
    Table 111. SIMILASAN Description and Business Overview
    Table 112. SIMILASAN Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. SIMILASAN Dry Eye Syndrome Product
    Table 114. SIMILASAN Recent Developments/Updates
    Table 115. Akorn Corporation Information
    Table 116. Akorn Description and Business Overview
    Table 117. Akorn Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Akorn Dry Eye Syndrome Product
    Table 119. Akorn Recent Developments/Updates
    Table 120. United Laboratories Corporation Information
    Table 121. United Laboratories Description and Business Overview
    Table 122. United Laboratories Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. United Laboratories Dry Eye Syndrome Product
    Table 124. United Laboratories Recent Developments/Updates
    Table 125. Sun Pharmaceutical Corporation Information
    Table 126. Sun Pharmaceutical Description and Business Overview
    Table 127. Sun Pharmaceutical Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Sun Pharmaceutical Dry Eye Syndrome Product
    Table 129. Sun Pharmaceutical Recent Developments/Updates
    Table 130. Jianfeng Group Corporation Information
    Table 131. Jianfeng Group Description and Business Overview
    Table 132. Jianfeng Group Dry Eye Syndrome Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Jianfeng Group Dry Eye Syndrome Product
    Table 134. Jianfeng Group Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Dry Eye Syndrome Distributors List
    Table 138. Dry Eye Syndrome Customers List
    Table 139. Dry Eye Syndrome Market Trends
    Table 140. Dry Eye Syndrome Market Drivers
    Table 141. Dry Eye Syndrome Market Challenges
    Table 142. Dry Eye Syndrome Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Dry Eye Syndrome
    Figure 2. Global Dry Eye Syndrome Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Dry Eye Syndrome Market Share by Type in 2023 & 2030
    Figure 4. Artificial Tears Product Picture
    Figure 5. Anti-inflammatory Drugs Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Dry Eye Syndrome Market Value Comparison by Distribution Channel (2024-2030) & (US$ Million)
    Figure 8. Global Dry Eye Syndrome Market Share by Distribution Channel in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Retail Pharmacy
    Figure 11. Others
    Figure 12. Global Dry Eye Syndrome Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Dry Eye Syndrome Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Dry Eye Syndrome Sales (2019-2030) & (M Units)
    Figure 15. Global Dry Eye Syndrome Average Price (US$/Unit) & (2019-2030)
    Figure 16. Dry Eye Syndrome Report Years Considered
    Figure 17. Dry Eye Syndrome Sales Share by Manufacturers in 2023
    Figure 18. Global Dry Eye Syndrome Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Dry Eye Syndrome Players: Market Share by Revenue in 2023
    Figure 20. Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Dry Eye Syndrome Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Dry Eye Syndrome Sales Market Share by Country (2019-2030)
    Figure 23. North America Dry Eye Syndrome Revenue Market Share by Country (2019-2030)
    Figure 24. United States Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Dry Eye Syndrome Sales Market Share by Country (2019-2030)
    Figure 27. Europe Dry Eye Syndrome Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Dry Eye Syndrome Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Dry Eye Syndrome Revenue Market Share by Region (2019-2030)
    Figure 35. China Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Dry Eye Syndrome Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Dry Eye Syndrome Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Dry Eye Syndrome Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Dry Eye Syndrome Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Dry Eye Syndrome Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Dry Eye Syndrome by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Dry Eye Syndrome by Type (2019-2030)
    Figure 56. Global Dry Eye Syndrome Price (US$/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Dry Eye Syndrome by Distribution Channel (2019-2030)
    Figure 58. Global Revenue Market Share of Dry Eye Syndrome by Distribution Channel (2019-2030)
    Figure 59. Global Dry Eye Syndrome Price (US$/Unit) by Distribution Channel (2019-2030)
    Figure 60. Dry Eye Syndrome Value Chain
    Figure 61. Dry Eye Syndrome Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS